Default company panoramic image

Accelerated Medical Diagnostics Inc.

We will enhance the lives of cancer patients by providing proprietary assays for predicting which patients will respond to chemotherapy.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Davis, CA, USA
  • Currency USD
  • Founded November 2012
  • Employees 5
  • Incorporation Type C-corp
  • Website

Company Summary

The goal of Accelerated Medical Diagnostics is to provide personalized therapy for cancer patients--specifically for those undergoing widely prescribed platinum-based chemotherapy. Our product, PlatinDx, is a diagnostic assay for predicting which patients will respond to platinum-based chemotherapy. This predictive technology does not require patient or tumor genotype information or culturing of tumor cells.


  • Default avatar
    George Cimino, PhD
    VP of Development

    Former Founder and VP of Product Development at Cerus Inc.

  • Default avatar
    Paul Henderson, PhD

    Faculty member of the UC Davis Department of Internal Medicine with over ten years of experience in applying mass spectrometry to cancer research

  • Default avatar
    Chong-xian Pan, MD, PhD

    Practicing Clinical Oncologist and Associate Professor of Medicine at the UC Davis Department of Internal Medicine

  • Default avatar
    William Hope, MBA
    Business Development Consultant

    MBA, University of Chicago Booth School of Business Emphasis in Strategic Management, Finance, and Entrepreneurship

  • Default avatar
    Maike Zimmermann, PhD
    Postdoctoral Fellow

    Recent PhD Graduate in Biochemistry Magna cum laude (very good) Department of Pharmacology University of Bielefeld (Germany), currently funded by the company to do research at UC Davis.

  • Default avatar
    Neil Thompson, PhD

    Assistant Professor (MIT, Sloan School of Management) 2013 –
    Entrepreneurship and Strategy


  • Default avatar
    DLA Piper/Fenwick and West
    Default avatar
    Bay Valley Accounting Professionals

Previous Investors

  • Default avatar
    NIH/NCI SBIR Contracts